Measles eradication in the Americas: Progress to date

Journal of Infectious Diseases

Volumn 189, Issue SUPPL. 1, 2004, Pages

  De Quadros, Ciro A ^a,b   Izurieta, Hector ^a   Venczel, Linda ^a   Carrasco, Peter ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b Albert B Sabin Vaccine Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; COLOMBIA; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; ERADICATION THERAPY; GENOTYPE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; MEASLES; MONITORING; PEDIATRICS; PRIORITY JOURNAL; TREATMENT PLANNING; VACCINATION; VENEZUELA; WESTERN HEMISPHERE; WORLD HEALTH ORGANIZATION;

EID: 2442461164     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377741     Document Type: Article

References (14)

1. World Health Organization, United Nations Children's Fund. Joint statement on strategies to reduce measles mortality worldwide [WHO/ V&B/01.40]. Geneva: World Health Organization, 2001.
2. Markowitz LE, Preblud SR, Fine PEM, et al. Duration of measles vaccine-induced immunity. Pediatr Infect Dis J 1990; 9:101-10.
3. Fine PEM, Clarkson JA. Measles in England and Wales: an analysis of factors underlying seasonal patterns. Int J Epidemiol 1982; 11:5-14.
4. Pan American Health Organization. Measles elimination by the year 2000. EPI Newsl 1994; 16:1-2.
5. de Quadras CA, Hersh BS, Olive JM, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996; 275:224-9.
6. Black FL. Measles. In: Evans AS, ed. Viral infections of humans. Epidemiology and control. 3rd ed. New York: Plenum Publishing, 1989: 451-65.
7. Redd SC, Markowitz LE, Katz S. Measles vaccine. In: Plotkin S, Orenstein W, eds. Vaccines. 3rd ed. Philadelphia: WB Saunders, 1999:222-66.
8. Pan American Health Organization. Measles in the Americas. EPI Newsl 1997; 19:1-3.
9. Hersh BS, Tambini G, Nogueira AC, Carrasco P, de Quadras CA. Review of measles surveillance data in the Americas, 1996-99. Lancet 2000; 355:1943-8.
10. Izurieta H, Venczel L, Dietz V, et al. Monitoring measles eradication in the Region of the Americas: critical activities and tools. J Infect Dis 2003; 187(Suppl 1):S133-9.
11. Hospedales CJ. Update on elimination of measles in the Caribbean. West Indian Med J 1992; 41:43-4.
12. Rota PA, Rota JS, Redd SB, Papania MR, Bellini WJ. Geneatic analysis of measles viruses isolated in the United States between 1989 and 2001: absence of an endemic genotype since 1994. J Infect Dis 2004; 189(Suppl 1):S160-4.
13. Camargo MC, de Moraes C, Souza V, Matos MR, Pannuti CS. Predictors related to the occurrence of a measles epidemic in the city of São Paulo in 1997. Rev Panam Salud Publica 2000; 7:359-65.
14. Acharya A, Diaz-Ortega JL, Tambini G, de Quadros C, Arita I. Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis. Vaccine 2002; 20:3332-81.